Skin Cancer and the Pivotal Role of Nurses in Clinical Trials
In the Fight Against Skin Cancer
Oncology nurses play a crucial role in biomarker testing as well as guiding patients through the entire clinical trial process. At the 2024 European Society for Medical Oncology Congress, Elizabeth Burton, PhD, discussed research indicating that nurses are pivotal in facilitating patient understanding and managing safety during clinical trials focused on skin cancer.
Research Insights
Burton, who is the director of Research Planning and Development at The University of Texas MD Anderson Cancer Center, presented findings from a phase 2 trial investigating neoadjuvant nivolumab (Opdivo) and relatlimab (Opdualag) in patients with stage IIIb or IV resectable melanoma. She stated, “There’s a tremendous opportunity to look at the biology and the mechanisms of the things that are happening in the patients who respond.”
- In-depth analysis of gene expression profiles from patients’ baseline tissues.
- Findings showed insights into the tumor microenvironment.
- The B7-H3 protein may help predict response to nivolumab combined with relatlimab.
The Role of Oncology Nurses
The oncology nursing team is absolutely pivotal for recruitment and ongoing patient support. Burton highlights their role as critical partners who shepherd patients through their clinical trial journey, ensuring they contribute to our understanding of skin cancer mechanisms effectively.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.